COLLIER ALAN BRIAN (CEO) purchased 0.1% of their position (34K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $425.30 — a small addition. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 6/6/2019ACC: 0001645470-19-000037
Officer· CEO
Since Jun 2016
+34K
Net shares
Net buyer
$425.30
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
34K acquired
Non-Derivative Transactions6
Common Stock
Direct
Shares
+10K
Price / share
$0.01
Trade value
$130.00
% of position
0.0%
6/4/2019
24.16M→24.17M
Common Stock
Direct
Shares
+1K
Price / share
$0.01
Trade value
$12.80
% of position
0.0%
6/4/2019
24.17M→24.17M
Common Stock
Direct
Shares
+2K
Price / share
$0.01
Trade value
$25.60
% of position
0.0%
6/4/2019
24.17M→24.17M
Common Stock
Direct
Shares
+1K
Price / share
$0.01
Trade value
$12.40
% of position
0.0%
6/4/2019
24.17M→24.17M
Common Stock
Direct
Shares
+15K
Price / share
$0.01
Trade value
$183.00
% of position
0.1%
6/4/2019
24.17M→24.19M
Common Stock
Direct
Shares
+5K
Price / share
$0.01
Trade value
$61.50
% of position
0.0%
6/4/2019
24.19M→24.19M
Total
Net shares
+34K
Net value
$425.30
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2019 | P · Purchase | +10K | $0.01 | $130.00 | 0.0% | 24.16M | 24.17M |
| Common Stock Direct | 6/4/2019 | P · Purchase | +1K | $0.01 | $12.80 | 0.0% | 24.17M | 24.17M |
| Common Stock Direct | 6/4/2019 | P · Purchase | +2K | $0.01 | $25.60 | 0.0% | 24.17M | 24.17M |
| Common Stock Direct | 6/4/2019 | P · Purchase | +1K | $0.01 | $12.40 | 0.0% | 24.17M | 24.17M |
| Common Stock Direct | 6/4/2019 | P · Purchase | +15K | $0.01 | $183.00 | 0.1% | 24.17M | 24.19M |
| Common Stock Direct | 6/4/2019 | P · Purchase | +5K | $0.01 | $61.50 | 0.0% | 24.19M | 24.19M |
| Total | +34K | $425.30 | ||||||
Derivative Transactions0
No derivative transactions reported